These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32270498)

  • 21. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facing the COVID-19 outbreak: What should we know and what could we do?
    Yang Y; Shang W; Rao X
    J Med Virol; 2020 Jun; 92(6):536-537. PubMed ID: 32091134
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
    Liu M; Feng RE; Li Q; Zhang HK; Wang YG
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 - A Brief Review of Radiology Testing.
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101059. PubMed ID: 32912602
    [No Abstract]   [Full Text] [Related]  

  • 28. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
    J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
    Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
    Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.
    Jiang C; Yao X; Zhao Y; Wu J; Huang P; Pan C; Liu S; Pan C
    Microbes Infect; 2020; 22(6-7):236-244. PubMed ID: 32405236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
    Jiang X; Rayner S; Luo MH
    J Med Virol; 2020 May; 92(5):476-478. PubMed ID: 32056235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronavirus vaccine-associated lung immunopathology-what is the significance?
    Bottazzi ME; Strych U; Hotez PJ; Corry DB
    Microbes Infect; 2020 Oct; 22(9):403-404. PubMed ID: 32599077
    [No Abstract]   [Full Text] [Related]  

  • 36. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19, SARS and MERS: A neurological perspective.
    Ng Kee Kwong KC; Mehta PR; Shukla G; Mehta AR
    J Clin Neurosci; 2020 Jul; 77():13-16. PubMed ID: 32417124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.
    Rabaan AA; Al-Ahmed SH; Haque S; Sah R; Tiwari R; Malik YS; Dhama K; Yatoo MI; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Infez Med; 2020 Ahead Of Print Jun 1; 28(2):174-184. PubMed ID: 32275259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.